Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy
Primary Purpose
Prostate Cancer
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Lidocaine
Sponsored by

About this trial
This is an interventional treatment trial for Prostate Cancer focused on measuring prostate
Eligibility Criteria
Inclusion Criteria:
- Patients who are undergoing prostate ultrasound-guided biopsy from the practice of Drs. Diokno and Hollander.
- Patients must speak English.
- Patients must sign consent form.
Exclusion Criteria:
- Patients having received prior radiation to the pelvic area.
- Patients with any neurologic disorder that may interfere with pain sensation during biopsy.
- Allergy to Lidocaine
- Patients requiring additional anesthesia (e.g. anxiolytics)
Sites / Locations
- William Beaumont Hospital
Outcomes
Primary Outcome Measures
To determine if patients experience a significant difference in pain on the side of their prostate that had local anesthesia.
Secondary Outcome Measures
To determine if patients feel that they could tolerate such a procedure with no anesthesia
Full Information
NCT ID
NCT00441532
First Posted
February 28, 2007
Last Updated
November 22, 2011
Sponsor
William Beaumont Hospitals
1. Study Identification
Unique Protocol Identification Number
NCT00441532
Brief Title
Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy
Official Title
A Double-Blind Randomized Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy
Study Type
Interventional
2. Study Status
Record Verification Date
October 2010
Overall Recruitment Status
Completed
Study Start Date
August 2005 (undefined)
Primary Completion Date
August 2006 (Actual)
Study Completion Date
August 2006 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
William Beaumont Hospitals
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Patients at risk for having prostate cancer usually undergo a biopsy of their prostate. This is most often done in the private urology office. Recent studies have suggested that injection of local anesthesia (lidocaine) near the nerves of the prostate will improve pain sensation during the biopsy procedure. Local anesthesia can be given through a separate needle through the rectal probe just prior to biopsy. However, many urologists to date perform their biopsies without anesthesia. Some claim that the needle used for anesthesia causes pain itself. Others claim that the pain is so minimal that the additional use of lidocaine (and extra time) is not necessary. We plan to reexamine the use of lidocaine and perform the first study where each patient will receive lidocaine and placebo on separate sides of their prostate.
Detailed Description
Patients at risk for having prostate cancer usually undergo a biopsy of their prostate. This is most often done in the private urology office. A probe with an ultrasound is inserted into the rectum of the patient and biopsies are taken with a spring-loaded needle. Most urologists take four to six biopsies of each side of the prostate. Years ago, biopsies were traditionally done without any anesthesia. Patients experienced some pain with each firing of the spring-loaded needle, but this is generally tolerable. Recent studies have suggested that injection of local anesthesia (lidocaine) near the nerves of the prostate will improve pain sensation during the biopsy procedure. Local anesthesia can be given through a separate needle through the rectal probe just prior to biopsy. However, many urologists to date perform their biopsies without anesthesia. Some claim that the needle used for anesthesia causes pain itself. Others claim that the pain is so minimal that the additional use of lidocaine (and extra time) is not necessary. We plan to reexamine the use of lidocaine and perform the first study where each patient will receive lidocaine and placebo on separate sides of their prostate.
Patients will undergo the traditional prostate biopsy procedure. They will be in the urology center at William Beaumont Hospital. Patients will lie on their side and an ultrasound probe will be inserted into the rectum. The size of the prostate will be measured with the ultrasound probe. A study coordinator will hand the physician a syringe containing either 2.5mL of lidocaine or saline (placebo). Neither the patient nor the physician will know which solution the syringe contains. The 2.5mL of the first syringe will be injected in the traditional area that local anesthesia is injected (periprostatic area) on the right side. Next, the second syringe will be handed to the physician containing the opposite drug (lidocaine or saline) and the physician will inject this on the left side. Four to six biopsies will be taken on the right side, and the study coordinator will record patient pain on a 1 to 10 scale after injection of the 2.5mL, and after each biopsy. Biopsies will then be taken on the left side, and again, study coordinators will record results of patient pain on a 1 to 10 scale. At the end of the procedure, patients will be given a questionnaire to assess overall pain, tolerability of the procedure, and whether or not they could tell which side of their prostate received the anesthesia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer
Keywords
prostate
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
50 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Lidocaine
Primary Outcome Measure Information:
Title
To determine if patients experience a significant difference in pain on the side of their prostate that had local anesthesia.
Secondary Outcome Measure Information:
Title
To determine if patients feel that they could tolerate such a procedure with no anesthesia
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who are undergoing prostate ultrasound-guided biopsy from the practice of Drs. Diokno and Hollander.
Patients must speak English.
Patients must sign consent form.
Exclusion Criteria:
Patients having received prior radiation to the pelvic area.
Patients with any neurologic disorder that may interfere with pain sensation during biopsy.
Allergy to Lidocaine
Patients requiring additional anesthesia (e.g. anxiolytics)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ananias Diokno, M.D.
Organizational Affiliation
William Beaumont Hospitals
Official's Role
Principal Investigator
Facility Information:
Facility Name
William Beaumont Hospital
City
Royal Oak
State/Province
Michigan
ZIP/Postal Code
48073
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy
We'll reach out to this number within 24 hrs